tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Holding BRNS?
Track your performance easily

Barinthus Biotherapeutics (BRNS) Ownership - Who Owns Barinthus Biotherapeutics?

84 Followers

Barinthus Biotherapeutics (BRNS) Ownership Overview

3.65%0.03%24.29%72.02%
3.65%
Insiders
24.29% Other Institutional Investors
72.02% Public Companies and
Individual Investors
The ownership structure of Barinthus Biotherapeutics (BRNS) stock is a mix of institutional, retail, and individual investors. , 3.65% is owned by Insiders, and 72.02% is owned by Public Companies and Individual Investors.
The ownership structure of Barinthus Biotherapeutics (BRNS) stock is a mix of institutional, retail, and individual investors. Approximately 24.32% of the company’s stock is owned by Institutional Investors, 3.65% is owned by Insiders, and 72.02% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,243,377Insider3.19%1,211,049
104,209Insider0.27%101,500
48,256Insider0.12%47,001
23,000Insider0.06%22,402
11,568Institution0.03%11,267
3,000Insider<0.01%2,922
3,000Insider<0.01%2,922
1,700Insider<0.01%1,656

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,568Institution0.03%11,267

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Barinthus Biotherapeutics (BRNS)?
According to the latest TipRanks data, approximately 24.29% of the company's stock is held by institutional investors, 3.65% is held by insiders, and 72.02% is held by retail investors.
    What percentage of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.29% of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors.
      What percentage of Barinthus Biotherapeutics (BRNS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 72.02% of Barinthus Biotherapeutics (BRNS) stock is held by retail investors.
        Who owns the most shares of Barinthus Biotherapeutics (BRNS)?
        William Enright owns the most shares of Barinthus Biotherapeutics (BRNS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis